These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35463625)

  • 1. Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges.
    Yusuf AP; Zhang JY; Li JQ; Muhammad A; Abubakar MB
    Phytomed Plus; 2022 Aug; 2(3):100280. PubMed ID: 35463625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
    Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
    Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.
    Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences.
    Banerjee S; Baidya SK; Adhikari N; Ghosh B; Jha T
    J Mol Struct; 2023 Mar; 1275():134642. PubMed ID: 36467615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
    Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
    Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE
    Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.
    Gomaa AA; Abdel-Wadood YA
    Phytomed Plus; 2021 Aug; 1(3):100043. PubMed ID: 35399823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic neuropathies post-Covid 19 - review.
    Abdul-Salam State SE; Sfredel V; Mocanu CL; Albu CV; Bălășoiu AT
    Rom J Ophthalmol; 2022; 66(4):289-298. PubMed ID: 36589322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.
    Prasansuklab A; Theerasri A; Rangsinth P; Sillapachaiyaporn C; Chuchawankul S; Tencomnao T
    J Tradit Complement Med; 2021 Mar; 11(2):144-157. PubMed ID: 33520683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview on medicinal plants used for combating coronavirus: Current potentials and challenges.
    Abou Baker DH; Hassan EM; El Gengaihi S
    J Agric Food Res; 2023 Sep; 13():100632. PubMed ID: 37251276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural medicinal plant products as an immune-boosters: A possible role to lessen the impact of Covid-19.
    Islam SS; Midya S; Sinha S; Saadi SMAI
    Case Stud Chem Environ Eng; 2021 Dec; 4():100105. PubMed ID: 38620656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.
    Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E
    Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
    Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
    Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.